{
  "@context": "https://frontierpicks.com/schemas/dossier.v1.json",
  "ticker": "PM",
  "name": "Philip Morris International Inc.",
  "url": "https://frontierpicks.com/dossiers/PM/",
  "json_url": "https://frontierpicks.com/dossiers/PM.json",
  "status": "WATCHLIST",
  "current_conviction": "LOW",
  "archetype": {
    "code": "a4",
    "n": 4
  },
  "current_thesis": "Philip Morris International is more likely to lag the S&P 500 over three months: its shares trade at 29.0 times earnings while management guides U.S. ZYN profit near zero for the fourth quarter. The fourth-quarter report and 2027 outlook, expected in early February 2027, settle it.",
  "invalidation_trigger": "A daily close above $214.35, above the 2026-10-30 52-week high, which would show the shares leading; or fourth-quarter 2026 U.S. operating income clearly above the \"around zero\" management guided on 2026-10-21.",
  "catalyst_date": "2027-01-29",
  "catalyst_estimated": true,
  "portfolio": null,
  "pick": null,
  "themes": [],
  "tags": [],
  "sources": [],
  "caveats": [
    {
      "claim": "Shareholders' equity is negative, at −$7,937 million at 2026-09-30, against debt of $47,562 million, so price-to-book is not a meaningful measure for this company.",
      "source": "Form 10-Q for the third quarter of 2026",
      "as_of": "2026-10-23"
    }
  ],
  "source_links": [
    {
      "title": "pmi.com",
      "url": "https://www.pmi.com/investor-relations/press-releases-and-events/press-releases-overview/press-release-details?newsId=30486",
      "date": "2026-10-21"
    },
    {
      "title": "Philip Morris Beat Q3, Then Handed It Back: ZYN's 25% Price Cut Explained",
      "url": "https://www.tikr.com/blog/philip-morris-beat-q3-then-handed-it-back-zyns-25-price-cut-explained",
      "date": "2026-10-22"
    },
    {
      "title": "Philip Morris International Inc. - Form 10-Q - FY2026",
      "url": "https://www.sec.gov/Archives/edgar/data/0001413329/000162828026066976/pm-20260930.htm",
      "date": null
    }
  ],
  "evidence": [
    {
      "claim": "Third-quarter 2026 net revenue was $11.4 billion, up 5.5% reported and 7.1% organically; adjusted diluted EPS was $2.36, up 5.4%, and reported diluted EPS was $2.12, down 4.9%.",
      "source": "PMI third-quarter 2026 results release",
      "as_of": "2026-10-21"
    },
    {
      "claim": "The 2026 adjusted diluted EPS forecast is $8.29–8.44; the ex-currency range of $8.11–8.26 is unchanged, and the currency benefit was cut to $0.18 from $0.24.",
      "source": "PMI third-quarter 2026 results release",
      "as_of": "2026-10-21"
    },
    {
      "claim": "U.S. ZYN shipments rose 4.2% to 3.2 billion pouches in the third quarter, and IQOS heated-tobacco unit shipments rose 1.5% to 41.5 billion.",
      "source": "PMI third-quarter 2026 results release",
      "as_of": "2026-10-21"
    },
    {
      "claim": "U.S. adjusted operating income was $171 million in the third quarter, and fell 41.1% organically to $550 million over the first nine months of 2026.",
      "source": "PMI third-quarter 2026 results release",
      "as_of": "2026-10-21"
    },
    {
      "claim": "Management guided U.S. operating income to around zero or slightly negative in the fourth quarter of 2026, as ZYN moves to 20-pouch cans at about 25% less revenue per pouch.",
      "source": "2026-10-21 earnings call, as reported by TIKR",
      "as_of": "2026-10-22"
    },
    {
      "claim": "The quarterly dividend was raised 8.8% to $1.60, and the company plans no share repurchases in 2026.",
      "source": "PMI third-quarter 2026 results release",
      "as_of": "2026-10-21"
    },
    {
      "claim": "Operating margin was 42.5% in the quarter to 2026-09-30, against 39.3% a year earlier; free cash flow was $13,595 million over the four quarters to that date.",
      "source": "Form 10-Q for the third quarter of 2026",
      "as_of": "2026-10-23"
    },
    {
      "claim": "JPMorgan reinstated coverage at Neutral with a $200 price target on 2026-11-10, after Stifel kept a Buy rating and raised its target to $232 from $205 on 2026-11-03.",
      "source": "Benzinga analyst ratings reports",
      "as_of": "2026-11-10"
    }
  ],
  "view_changes": [],
  "frame": {
    "as_of": "2026-11-15",
    "business": "Philip Morris International sells Marlboro cigarettes and smoke-free nicotine products, mainly IQOS heated tobacco and ZYN nicotine pouches, to wholesalers and retailers worldwide. It earns money mostly through price increases on steady volumes. Revenue was $11,438 million in the quarter to 2026-09-30.",
    "change": {
      "now": "On 2026-10-21 the company reported third-quarter revenue up 5.5% to $11,438 million. It is moving most U.S. ZYN cans from 15 to 20 pouches at the same price, about 25% less revenue per pouch.",
      "next": "Management expects U.S. operating income to fall from $171 million in the third quarter to around zero in the fourth as U.S. spending rises. It guides organic operating income growth to the middle or lower half of 7–9%.",
      "linked": "More ZYN pouches for the same price adds pressure on Altria (MO), whose on! brand held 13.4% of U.S. pouch sales in the first quarter according to TIKR, and on British American Tobacco (BTI)."
    },
    "priced_in": "At the 2026-11-13 close (filed inputs to 2026-10-23) the shares trade at 29.0 times earnings, 21.1 times EV/EBIT and 8.1 times sales, with a 4.4% free-cash-flow yield. That holds only if revenue keeps growing near the 5.5% of the latest filed quarter and the operating margin stays near that quarter's 42.5% through the U.S. ZYN price reset.",
    "links": {
      "customers": [],
      "suppliers": [],
      "competitors": [
        {
          "ticker": "MO",
          "url": null
        },
        {
          "ticker": "BTI",
          "url": null
        }
      ]
    }
  },
  "filed_numbers": {
    "as_of": "2026-11-17",
    "sector": "Consumer Defensive",
    "financials": {
      "status": "ok",
      "reason": null,
      "close_date": "2026-11-17",
      "latest_quarter": "2026-09-30",
      "figures": {
        "revenue": {
          "status": "ok",
          "quarters": [
            {
              "end": "2026-09-30",
              "filed": "2026-10-23",
              "restated": null,
              "value_musd": 11438,
              "yoy_pct": 5.5
            },
            {
              "end": "2026-06-30",
              "filed": "2026-07-24",
              "restated": null,
              "value_musd": 11192,
              "yoy_pct": 10.4
            },
            {
              "end": "2026-03-31",
              "filed": "2026-04-24",
              "restated": null,
              "value_musd": 10146,
              "yoy_pct": 9.1
            },
            {
              "end": "2025-12-31",
              "filed": "2026-02-06",
              "restated": null,
              "value_musd": 10362,
              "yoy_pct": 6.8
            },
            {
              "end": "2025-09-30",
              "filed": "2025-10-24",
              "restated": null,
              "value_musd": 10845,
              "yoy_pct": 9.4
            },
            {
              "end": "2025-06-30",
              "filed": "2025-07-25",
              "restated": null,
              "value_musd": 10140,
              "yoy_pct": 7.1
            }
          ]
        },
        "gross_margin": {
          "status": "ok",
          "quarters": [
            {
              "end": "2026-09-30",
              "filed": "2026-10-23",
              "restated": null,
              "pct": 68.7
            },
            {
              "end": "2026-06-30",
              "filed": "2026-07-24",
              "restated": null,
              "pct": 68.4
            },
            {
              "end": "2026-03-31",
              "filed": "2026-04-24",
              "restated": null,
              "pct": 68.1
            },
            {
              "end": "2025-12-31",
              "filed": "2026-02-06",
              "restated": null,
              "pct": 65.6
            },
            {
              "end": "2025-09-30",
              "filed": "2025-10-24",
              "restated": "2026-10-23",
              "pct": 67.9
            },
            {
              "end": "2025-06-30",
              "filed": "2025-07-25",
              "restated": "2026-07-24",
              "pct": 67.7
            }
          ]
        },
        "operating_margin": {
          "status": "ok",
          "quarters": [
            {
              "end": "2026-09-30",
              "filed": "2026-10-23",
              "restated": null,
              "pct": 42.5
            },
            {
              "end": "2026-06-30",
              "filed": "2026-07-24",
              "restated": null,
              "pct": 40.5
            },
            {
              "end": "2026-03-31",
              "filed": "2026-04-24",
              "restated": null,
              "pct": 38.4
            },
            {
              "end": "2025-12-31",
              "filed": "2026-02-06",
              "restated": null,
              "pct": 32.6
            },
            {
              "end": "2025-09-30",
              "filed": "2025-10-24",
              "restated": null,
              "pct": 39.3
            },
            {
              "end": "2025-06-30",
              "filed": "2025-07-25",
              "restated": null,
              "pct": 36.6
            }
          ]
        },
        "pretax_income": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-10-23",
          "value_musd": 4594
        },
        "net_income": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-10-23",
          "four_quarters_end": "2026-09-30",
          "value_musd": 3313,
          "four_quarters_musd": 10709
        },
        "operating_cash_flow": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-10-23",
          "first_end": "2025-12-31",
          "value_musd": 15154
        },
        "capital_spending": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-10-23",
          "first_end": "2025-12-31",
          "value_musd": 1559
        },
        "free_cash_flow": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-10-23",
          "first_end": "2025-12-31",
          "value_musd": 13595
        },
        "diluted_share_change": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-10-23",
          "base_end": "2025-09-30",
          "pct": 0.1
        },
        "cash": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-10-23",
          "value_musd": 6683
        },
        "debt": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-10-23",
          "value_musd": 47562,
          "composition": "long-term debt and finance leases plus short-term borrowings"
        },
        "net_cash": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-10-23",
          "value_musd": -40879
        },
        "deferred_revenue": {
          "status": "not reported"
        },
        "backlog": {
          "status": "not reported"
        },
        "receivables": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-10-23",
          "value_musd": 5156
        },
        "inventory": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-10-23",
          "value_musd": 10326
        },
        "equity": {
          "status": "ok",
          "end": "2026-09-30",
          "filed": "2026-10-23",
          "value_musd": -7937
        },
        "market_value": {
          "status": "ok",
          "close_date": "2026-11-17",
          "basis_end": "2026-10-16",
          "basis_filed": "2026-10-23",
          "value_musd": 302971.5
        },
        "enterprise_value": {
          "status": "ok",
          "close_date": "2026-11-17",
          "basis_end": "2026-10-16",
          "basis_filed": "2026-10-23",
          "value_musd": 343850.5
        },
        "ev_sales": {
          "status": "ok",
          "close_date": "2026-11-17",
          "basis_end": "2026-10-16",
          "basis_filed": "2026-10-23",
          "multiple": 8
        },
        "ev_ebit": {
          "status": "ok",
          "close_date": "2026-11-17",
          "basis_end": "2026-10-16",
          "basis_filed": "2026-10-23",
          "multiple": 20.6
        },
        "pe": {
          "status": "ok",
          "close_date": "2026-11-17",
          "basis_end": "2026-10-16",
          "basis_filed": "2026-10-23",
          "multiple": 28.3
        },
        "pb": {
          "status": "not meaningful"
        },
        "fcf_yield": {
          "status": "ok",
          "close_date": "2026-11-17",
          "basis_end": "2026-10-16",
          "basis_filed": "2026-10-23",
          "pct": 4.5
        }
      }
    },
    "short_interest": {
      "status": "ok",
      "settlement": "2026-10-30",
      "published": "2026-11-10",
      "short_pct_of_outstanding": 0.95,
      "days_to_cover": 3.2,
      "change_pct": -14
    },
    "insiders": {
      "status": "not available yet",
      "as_of": null,
      "windows": []
    }
  },
  "body_markdown": "## Current Thesis\n\nPhilip Morris International is more likely to lag the S&P 500 over the next three months. The shares trade at 29.0 times earnings while management has guided U.S. ZYN profit to around zero in the fourth quarter of 2026. The fourth-quarter report and the 2027 outlook, expected in early February 2027, settle it.\n\nThe rating is Low because the business is growing but the next report carries a guided profit dip. On 2026-10-21 the company reported third-quarter revenue of $11,438 million, up 5.5% from a year earlier and 7.1% organically, and adjusted diluted earnings per share (EPS) of $2.36, up 5.4%. In the same release it kept its ex-currency 2026 adjusted EPS forecast at $8.11–8.26 and cut the expected currency benefit to $0.18 from $0.24. It also guided organic operating income growth to the middle or lower half of its 7–9% range.\n\nThe main problem is the U.S. pouch business. Most flagship ZYN cans are moving from 15 to 20 pouches at the same price. On the 2026-10-22 call, finance chief Massimo Andolina said this means about 25% less revenue per pouch, according to TIKR. Management expects U.S. operating income, $171 million in the third quarter, to be \"around zero or slightly negative\" in the fourth.\n\n## Bull Case\n\n- **Pricing still drives record profits.** The 2026-10-21 release showed $739 million of favourable pricing in the third quarter and record quarterly revenue, gross profit and operating income. The operating margin was 42.5% in the quarter to 2026-09-30, against 39.3% a year earlier (10-Q filed 2026-10-23).\n- **Cigarette volumes are holding up better than planned.** Cigarette volume was flat in the third quarter and down 1.2% over the first nine months of 2026. On 2026-10-21 the company dropped its earlier assumption of a 2–3% full-year decline.\n- **Cash funds a rising dividend.** Free cash flow was $13,595 million over the four quarters to 2026-09-30 (10-Q). On 2026-10-21 the board raised the quarterly dividend 8.8% to $1.60.\n- **Smoke-free sales are now a large share of revenue.** Smoke-free products made up more than 40% of third-quarter net revenue and about 42% of the year to date (2026-10-21 release). IQOS heated-tobacco shipments rose 1.5% to 41.5 billion units.\n- **Some analysts see room above the price.** Stifel kept a Buy rating and raised its target to $232 from $205 on 2026-11-03. Argus raised its target to $220 on 2026-10-26.\n\n## Bear Case\n\n- **U.S. profit has fallen sharply.** U.S. adjusted operating income fell 41.1% organically to $550 million over the first nine months of 2026 (2026-10-21 release). Management expects U.S. selling and administrative costs, about $370 million in the third quarter, to rise another 10% in the fourth, according to TIKR's 2026-10-22 summary of the call.\n- **ZYN growth has slowed.** U.S. ZYN shipments rose only 4.2% to 3.2 billion pouches in the third quarter (2026-10-21 release). A Jefferies analyst cited scanner data showing a mid-single-digit fall in U.S. ZYN volumes over the same quarter, as reported by TIKR on 2026-10-22.\n- **The valuation already assumes growth.** At the 2026-11-13 close the shares trade at 29.0 times reported earnings and 21.1 times operating profit including debt. TIKR put the forward multiple at 21.97 times on 2026-10-22, against a five-year average of 17.85 times.\n- **Balance sheet leaves no room for buybacks.** Debt was $47,562 million and shareholders' equity was negative $7,937 million at 2026-09-30 (10-Q). The company said on 2026-10-21 that it plans no share repurchases in 2026.\n- **The newest analyst rating sits at the price.** JPMorgan reinstated coverage at Neutral with a $200 target on 2026-11-10.\n- **Regulation keeps tightening.** On 2026-10-29 the UK health department extended its under-18 sales ban to nicotine products and all vapes. On 2026-11-12 Politico reported that European cities are asking for an EU-wide ban on cigarette filters.\n\n## Setup & Price Structure\n\nThe shares closed at $198.96 on 2026-11-13. That is 7.2% below the 52-week intraday high of $214.35 set on 2026-10-30, and 8.8% above the adjusted close three months earlier. The 50-day moving average is $195.68 and the 200-day moving average is $180.97, both from adjusted daily closes as of 2026-11-13. The 52-week closing low was $147.81 on 2025-12-05.\n\nOn report day, 2026-10-21, the shares closed at $197.46, down 1.22%, after trading near $194 (TIKR). They then rose to the 2026-10-30 high and fell back to close at $193.12 on 2026-11-09, below the 50-day average. They recovered to $198.96 by 2026-11-13. The price now sits just above the 50-day average and near JPMorgan's $200 target. A move back above the October high would mean investors are looking past the fourth-quarter profit dip.\n\n## Catalyst Calendar\n\n- **~2027-01-29 (est.):** Altria fourth-quarter 2026 report. Altria's on! pouch results show whether the cheaper ZYN cans are winning share from the main U.S. competitor.\n- **~2027-02-05 (est.):** Philip Morris International fourth-quarter 2026 results and 2027 outlook. This report shows whether U.S. operating income fell to around zero as guided, and whether 2027 EPS guidance supports a multiple of 29.0 times earnings.\n- **~2027-02-16 (est.):** CAGNY consumer conference presentation. Management usually restates or updates the year's forecast at this conference, which shows whether the 2027 outlook holds.\n\n## What Would Change Our Mind\n\nA daily close above $214.35, above the 2026-10-30 52-week high, which would show the shares leading; or fourth-quarter 2026 U.S. operating income clearly above the \"around zero\" management guided on 2026-10-21.\n\n## Correlation Notes\n\nA common market view is that tobacco shares trade as defensive holdings that lag when growth stocks rally. On 2026-11-09 the Nasdaq 100 rose 3% as chip stocks rebounded, and Philip Morris fell from $197.88 to $193.12. The shares are most closely linked to news from Altria (MO), which competes with ZYN through on!, and from British American Tobacco (BTI). Most revenue is earned outside the United States, so the dollar affects reported EPS. The 2026-10-21 cut to the currency benefit, to $0.18 from $0.24, shows how currency moves feed into the forecast.",
  "first_seen": "2026-11-12",
  "last_analyzed": "2026-11-15T12:02:41+00:00",
  "last_synthesized": "2026-11-15",
  "date_modified": "2026-11-16",
  "license": "Content © FrontierPicks. Cite the canonical URL."
}